Home
Faculty of Medicine

News archive for Faculty of Medicine

The Norhed II project “Safeworkers” presents the first course in the Virtual School of Occupational Health, “Chemical Hazards in the Work Environment”, offered through the online learning platform at Muhimbili University of Health and Allied Sciences (MUHAS), Tanzania.
Sexual or gender minorities in Nepal experience mental health issues due to widespread violence and stigmatization. A group of researchers from the University of Bergen (UiB) and Nepal will investigate whether peer counseling can improve mental health and reduce exposure to violence for this group.
Our multidisciplinary research group aims to investigate pediatric hip disorders through multiple approaches. That is why our research includes genetic epidemiology with the purpose of unravelling why some individuals are prone to getting these disorders. Recently, we published a large genome-wide association study (GWAS) on hip dysplasia, implicating a collagen gene in the development of hip... Read more
Developmental dysplasia of the hip (DDH) is a congenital disorder in which the etiology, risk factors and life course are not fully understood.
In October, the Pandemic Centre is offering an interdisciplinary course for students on preparedness for health crises. The course is primarily aimed at PhD candidates and master's students and will address a range of exciting issues in collaboration with some of the leading experts at UiB.
Genes can indirectly influence the age at which girls have their first period by accelerating weight gain in childhood, a known risk factor for early puberty, a study from the University of Bergen and University of Cambridge has found. Other genes can directly affect age of puberty, some with profound effects.
We give you a springtime update on the activities of NutriNOR – Norway’s national research school in nutrition.
Karen Rosnes Gissum defended June 28, 2024 her PhD thesis "Unveiling the Complexities: Patients’ and Healthcare Providers’ Perspectives on Understanding and Managing Ovarian Cancer" at the University of Bergen. This is a unique CCBIO doctorate work focusing on the patient and healthcare worker perspective and not the actual research. Nevertheless, objective measures like biomarkers were seen as... Read more
Many women experience symptoms such as brain fog, fatigue, and abdominal pain in the first part of pregnancy. Ground-breaking research from UiB can provide new answers to how genes can trigger such symptoms.
In a new doctoral work at CCBIO, by Christiane Helgestad Gjerde, the group has established a 3D in vitro model of high-grade serous ovarian carcinoma to assess the efficacy of traditional chemotherapy and novel cell-based immunotherapies. This model makes out a more realistic mini tumor, making it possible to test which therapy that works on this type of cancer. The knowledge provided from this... Read more
Professor in Medicine, Cecilie Svanes, was recently appointed to Honorary doctor at the Faculty of medicine, Uppsala University.
Hassan Abdel-Raouf Abdel-Wahab Mohamed Ali defended his thesis for the PhD-degree at the University of Bergen on the 24th of May. The title of the thesis is: " "Stemness and osteogenic differentiation of induced pluripotent stem cells generated in xeno-free conditions" ".
Victoria Xenaki defended her thesis for the PhD-degree at the University of Bergen on the 23 of May. The title of the thesis is: " Nanosafety aspects: Dental health care workers’ perception of nanomaterials and in vitro nanotoxicity assessment using new approach methodologies ".
Research at UiB and Haukeland gives insight into a particular form of diabetes that can be treated with alternative drugs.
The TREAT CONSORTIUM presented five oral abstracts at the Bold Ideas for Brighter Futures Conference in Stockholm 15-16 May 2024
BORTEM-17 interim analysis results and small molecule inhibitor targeting CSPG4/NG2 in glioblastoma at American Association for Cancer Research (AACR 2024) April 5-10, 2024
BORTEM-17 interim analysis results and small molecule inhibitor targeting CSPG4/NG2 in glioblastoma at American Association for Cancer Research (AACR 2024) April 5-10, 2024

Pages